MARTINEZ, Calif.--(BUSINESS WIRE)--ExThera Medical is pleased to announce that published data from a preliminary European study demonstrating in vitro adsorption of human circulating tumor cells (CTC) ...
MARTINEZ, Calif.--(BUSINESS WIRE)--Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of ...
ExThera Medical, a developer of blood filtration systems and biotechnologies, has received Expedited Access Pathway (EAP) designation from FDA for its latest technology, the Seraph 100 blood filter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback